Evaluation of efficacy and tolerability of first-line therapies in NMOSD. Poupart J, Giovannelli J, Deschamps R, Audoin B, et al. Neurology 2020;94:e1645-e1656.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Poupart J, Giovannelli J, Deschamps R, Audoin B, et al. Evaluation of efficacy and tolerability of first-line therapies in NMOSD. Neurology 2020;94:e1645-e1656.
PMID: 32170036